ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 85 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $18,006,000 | -56.7% | 2,108,442 | +1.4% | 0.01% | -46.2% |
| Q3 2018 | $41,621,000 | -17.6% | 2,078,994 | +6.4% | 0.01% | -23.5% |
| Q2 2018 | $50,486,000 | +17.8% | 1,954,556 | +9.0% | 0.02% | +6.2% |
| Q1 2018 | $42,845,000 | -26.1% | 1,792,672 | +4.8% | 0.02% | -23.8% |
| Q4 2017 | $57,992,000 | +30583.6% | 1,711,191 | +15163.5% | 0.02% | – |
| Q4 2016 | $189,000 | +2.2% | 11,211 | -0.6% | 0.00% | – |
| Q3 2016 | $185,000 | -7.0% | 11,274 | -17.8% | 0.00% | – |
| Q1 2016 | $199,000 | -93.9% | 13,710 | -88.1% | 0.00% | -100.0% |
| Q4 2015 | $3,258,000 | +70.5% | 115,050 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $1,911,000 | +77.1% | 114,131 | +177.3% | 0.00% | – |
| Q2 2015 | $1,079,000 | – | 41,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,601,351 | $43,963,000 | 9.03% |
| Granite Point Capital Management, L.P. | 256,031 | $4,327,000 | 3.45% |
| Opaleye Management Inc. | 285,000 | $4,817,000 | 2.84% |
| Brenner West Capital Advisors | 1,221,463 | $20,643,000 | 2.28% |
| ARMISTICE CAPITAL, LLC | 536,000 | $9,058,000 | 2.14% |
| NEXTHERA CAPITAL LP | 151,670 | $2,563,000 | 1.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 185,234 | $3,130,000 | 1.41% |
| Cheyne Capital Management (UK) LLP | 144,765 | $2,448,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 270,000 | $4,563,000 | 1.16% |
| Mosaic Family Wealth, LLC | 123,314 | $2,084,000 | 0.96% |